Viewing Study NCT03450967


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-01-06 @ 2:46 AM
Study NCT ID: NCT03450967
Status: UNKNOWN
Last Update Posted: 2021-08-10
First Post: 2018-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
Sponsor: Samsung Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module